Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency

Por Lungu, Octavian, Panagiotidis, Christos A., Annunziato, Paula W., Gershon, Anne A., Silverstein, Saul J.
Publicado em 1998

Varicella-Zoster Virus Proteins in Skin Lesions: Implications for a Novel Role of ORF29p in Chickenpox

Por Annunziato, Paula W., Lungu, Octavian, Panagiotidis, Christos, Zhang, Jing H., Silvers, David N., Gershon, Anne A., Silverstein, Saul J.
Publicado em 2000

Herpes zoster vaccine live: A 10 year review of post-marketing safety experience

Por Willis, English D., Woodward, Meredith, Brown, Elizabeth, Popmihajlov, Zoran, Saddier, Patricia, Annunziato, Paula W., Halsey, Neal A., Gershon, Anne A.
Publicado no Vaccine (2017)

Safety and tolerability of zoster vaccine in adults ≥60 years old

Por Murray, Alexander V., Reisinger, Keith S., Kerzner, Boris, Stek, Jon E., Sausser, Timothy A., Xu, Jin, Wang, William W., Chan, Ivan S.F., Annunziato, Paula W., Parrino, Janie
Publicado em 2011

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

Por Boeckh, Michael J, Arvin, Ann M, Mullane, Kathleen M, Camacho, Luis H, Winston, Drew J, Morrison, Vicki A, Hurtado, Kimberly, Durrand Hall, Jessie, Pang, Lei, Su, Shu-Chih, Kaplan, Susan S, Annunziato, Paula W, Popmihajlov, Zoran
Publicado no Open Forum Infect Dis (2020)

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years

Por Schmader, Kenneth E., Levin, Myron J., Gnann, John W., McNeil, Shelly A., Vesikari, Timo, Betts, Robert F., Keay, Susan, Stek, Jon E., Bundick, Nickoya D., Su, Shu-Chih, Zhao, Yanli, Li, Xiaoming, Chan, Ivan S. F., Annunziato, Paula W., Parrino, Janie
Publicado no Clin Infect Dis (2012)

Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine

Por Levin, Myron J., Schmader, Kenneth E., Gnann, John W., McNeil, Shelly A., Vesikari, Timo, Betts, Robert F., Keay, Susan, Stek, Jon E., Bundick, Nickoya D., Su, Shu-Chih, Zhao, Yanli, Li, Xiaoming, Chan, Ivan S. F., Annunziato, Paula W., Parrino, Janie
Publicado no J Infect Dis (2013)

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Por Mehrotra, Devan V., Janes, Holly E., Fleming, Thomas R., Annunziato, Paula W., Neuzil, Kathleen M., Carpp, Lindsay N., Benkeser, David, Brown, Elizabeth R., Carone, Marco, Cho, Iksung, Donnell, Deborah, Fay, Michael P., Fong, Youyi, Han, Shu, Hirsch, Ian, Huang, Ying, Huang, Yunda, Hyrien, Ollivier, Juraska, Michal, Luedtke, Alex, Nason, Martha, Vandebosch, An, Zhou, Honghong, Cohen, Myron S., Corey, Lawrence, Hartzel, Jonathan, Follmann, Dean, Gilbert, Peter B.
Publicado no Ann Intern Med (2020)

Safety of Zoster Vaccine in Elderly Adults Following Documented Herpes Zoster

Por Morrison, Vicki A., Oxman, Michael N., Levin, Myron J., Schmader, Kenneth E., Guatelli, John C., Betts, Robert F., Gelb, Larry D., Pachucki, Constance T., Keay, Susan K., Menzies, Barbara, Griffin, Marie R., Kauffman, Carol A., Marques, Adriana R., Toney, John F., Simberkoff, Michael S., Serrao, Richard, Arbeit, Robert D., Gnann, John W., Greenberg, Richard N., Holodniy, Mark, Keitel, Wendy A., Yeh, Shingshing S., Davis, Larry E., Crawford, George E., Neuzil, Kathy M., Johnson, Gary R., Zhang, Jane H., Harbecke, Rith, Chan, Ivan S. F., Keller, Paul M., Williams, Heather M., Boardman, Kathy D., Silber, Jeffrey L., Annunziato, Paula W.
Publicado em 2013